Glucos B. Braun

Glucos B. Braun is an intravenous solution that contains glucose monohydrate as its active ingredient. It is supplied in a sterile liquid form for parenteral administration, providing a carbohydrate source for energy metabolism. The product is marketed in the European Union and is available by prescription. It is used in hospital settings to support patients who cannot receive nutrition orally or who require rapid correction of low blood glucose levels.

Glucos B. Braun is indicated for several clinical situations where intravenous carbohydrate and fluid support are needed.

- Treatment of hypoglycemia when oral glucose is not feasible. - Fluid and electrolyte replacement in patients unable to tolerate oral intake. - Component of total parenteral nutrition regimens to provide caloric energy. - Support during peri‑operative fasting or postoperative recovery. - Management of electrolyte imbalances associated with dehydration.

Intravenous administration of glucose monohydrate can produce a range of effects, most of which are related to changes in plasma glucose and fluid balance.

Common: - Transient hyperglycemia. - Local irritation or pain at the infusion site. - Mild electrolyte shifts such as low potassium. - Nausea or vomiting.

Serious: - Severe hyperglycemia leading to osmotic diuresis. - Allergic reaction including rash, itching, or anaphylaxis. - Fluid overload causing pulmonary edema.

When using Glucos B. Braun, clinicians should consider several precautionary measures to minimize risks and ensure appropriate therapy.

- Assess blood glucose levels before and during infusion. - Adjust dose in patients with renal or hepatic impairment. - Monitor electrolytes, especially potassium and sodium, during prolonged use. - Use caution in patients with heart failure or risk of fluid overload. - Avoid rapid infusion rates in neonates and infants. - Consider pregnancy status; safety data are limited.

Glucose solutions may interact with other medications or clinical conditions, influencing efficacy or safety.

Avoid: - Concurrent administration of high‑dose insulin without glucose monitoring. - Co‑infusion with potassium chloride solutions that may precipitate. - Use with drugs that cause severe hypoglycemia without appropriate glucose supplementation.

Use with caution: - Diuretics that affect electrolyte balance; monitor serum levels. - Corticosteroids that increase blood glucose; adjust infusion rate. - Beta‑blockers that mask hypoglycemia symptoms; observe closely.